Cancer-associated histone mutation H2BG53D disrupts DNA-histone octamer interaction and promotes oncogenic phenotypes.
Wan YCE, Leung TCS, Ding D, Sun X, Liu J, Zhu L, Kang TZE, Yang D, Zhang Y, Zhang J, Qian C, Huen MSY, Li Q, Chow MZY, Zheng Z, Han J, Goel A, Wang X, Ishibashi T, Chan KM.
Wan YCE, et al. Among authors: chow mzy.
Signal Transduct Target Ther. 2020 Mar 6;5(1):27. doi: 10.1038/s41392-020-0131-0.
Signal Transduct Target Ther. 2020.
PMID: 32296031
Free PMC article.
No abstract available.